European Neuropsychopharmacology
Volume 21, Issue 4 , Pages 344-353 , April 2011

Mapping of CBV changes in 5-HT1A terminal fields by functional MRI in the mouse brain

  • Thomas Mueggler

      Affiliations

    • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    • Current address: F. Hoffmann-La Roche Ltd., Pharmaceutical Research Neuroscience, CH-4070 Basel, Switzerland. Tel.: +41 61 687 4027; fax: +41 61 687 1910.
    • Contributed equally to this work.
    • ,
  • Florence Razoux

      Affiliations

    • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    • Contributed equally to this work.
    • ,
  • Holger Russig

      Affiliations

    • Brain Research Institute, University and ETH Zurich, Zurich, Switzerland
    • ,
  • Anna Buehler

      Affiliations

    • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    • ,
  • Tamara B. Franklin

      Affiliations

    • Brain Research Institute, University and ETH Zurich, Zurich, Switzerland
    • ,
  • Christof Baltes

      Affiliations

    • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    • ,
  • Isabelle M. Mansuy

      Affiliations

    • Brain Research Institute, University and ETH Zurich, Zurich, Switzerland
    • ,
  • Markus Rudin

      Affiliations

    • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    • Institute of Pharmacology and Toxicology, University Zurich, Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Institute for Biomedical Engineering, University and ETH Zurich, Institute of Pharmacology and Toxicology, University of Zurich, HIT E.22.4, Wolfgang Pauli Strasse 27, CH-8093 Zurich, Switzerland. Tel.: +41 44 633 7604; fax: +41 44 633 1187.

Received 11 December 2009 ,Revised 14 June 2010 ,Accepted 19 June 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-977X(10)00137-9

doi: 10.1016/j.euroneuro.2010.06.010

European Neuropsychopharmacology
Volume 21, Issue 4 , Pages 344-353 , April 2011

Article Tools

* Image Usage & Resolution